These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

84 related articles for article (PubMed ID: 5368849)

  • 21. [A method of primary selection of antitumor agents].
    Karaivanova MKh
    Vopr Onkol; 1971; 17(2):62-6. PubMed ID: 5567711
    [No Abstract]   [Full Text] [Related]  

  • 22. Immunotherapy and chemotherapy of Moloney sarcoma virus-induced tumors in mice.
    Fefer A
    Cancer Res; 1969 Dec; 29(12):2177-83. PubMed ID: 5369675
    [No Abstract]   [Full Text] [Related]  

  • 23. Experimental approach for the search of effective drug combination in cancer chemotherapy.
    Bello JL; Kariev NI; Mainardi JV; Betancourt M; Lage A; Barroso MC; Alfonso L
    Neoplasma; 1982; 29(1):65-71. PubMed ID: 7070556
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Comparative studies of the cytostatic effect of a new N-Lost derivative "IMET 3393" and Endoxan in 3 experimental mice tumors (Ehrlich ascites carcinoma, sarcoma 180 solid, leukemia LAJ I)].
    Schnabel R; Jungstand W; Gutsche W; Grimm H; Fritsch S
    Acta Biol Med Ger; 1967; 19(4):543-58. PubMed ID: 5596676
    [No Abstract]   [Full Text] [Related]  

  • 25. Actinomycin D: effects on Ridgway osteogenic sarcoma in mice.
    Schwartz HS; Sodergren JE; Sternberg SS; Philips FS
    Cancer Res; 1966 Sep; 26(9):1873-9. PubMed ID: 5224225
    [No Abstract]   [Full Text] [Related]  

  • 26. [Effect of various aminothiol compounds on the toxicity and specific activity of antitumor preparations].
    Spasskaia IG; Iurchenko NIa; Rachinskiĭ FIu
    Vopr Onkol; 1968; 14(10):75-9. PubMed ID: 5724801
    [No Abstract]   [Full Text] [Related]  

  • 27. [Antitumor activity of doxorubicin in the treatment of hemocytoblastosis La and various ascites tumors in mice].
    Ul'ianova LA; Tarasova VE; Bazhanov VS; Iudina OI; Gol'dberg LE
    Antibiotiki; 1984 Nov; 29(11):861-6. PubMed ID: 6524889
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Inhibition by pancreatic ribonuclease of experimental tumour metastasizing in mice.
    Graffi A; Arnold W
    Acta Biol Med Ger; 1973 May; 30(5):K15-8. PubMed ID: 4733624
    [No Abstract]   [Full Text] [Related]  

  • 29. A metronomic schedule of cyclophosphamide combined with PEGylated liposomal doxorubicin has a highly antitumor effect in an experimental pulmonary metastatic mouse model.
    Shiraga E; Barichello JM; Ishida T; Kiwada H
    Int J Pharm; 2008 Apr; 353(1-2):65-73. PubMed ID: 18155369
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Experimental studies with Proresid in inoculated sarcoma of the mouse].
    Hilscher W; Ritzl F; Stockhausen W; Witt I
    Strahlentherapie; 1970 Oct; 140(4):460-2. PubMed ID: 5510464
    [No Abstract]   [Full Text] [Related]  

  • 31. Tempol reduces the therapeutic effect of cyclophosphamide on an experimental tumour model.
    Kaledin VI; Popova NA; Nikolin VP; Vasilieva ED; Kirilyuk IA; Grigor'ev IA
    Free Radic Res; 2009 Jul; 43(7):685-90. PubMed ID: 19526393
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Evaluation of anti-blastoma effects of tetravaccine in combination with chemotherapy].
    Khorava PA; Gambashidze KG
    Georgian Med News; 2006 Aug; (137):111-4. PubMed ID: 16980764
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Hemodialysis in cancer chemotherapy.
    Galletti PM; Pasqualino A; Geering RG
    Trans Am Soc Artif Intern Organs; 1966; 12():20-5. PubMed ID: 5960706
    [No Abstract]   [Full Text] [Related]  

  • 34. [Enhancement of anti-cancer effect by potential lethal damage repair(PLDR)-inhibitors].
    Akagi K; Sogawa M; Tanaka Y
    Gan No Rinsho; 1983 Oct; 29(13):1613-8. PubMed ID: 6668669
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Changes in tumor-associated NK 1.1+ large granular lymphocyte precursors after cyclophosphamide injection: in vitro characterization and potential therapeutic application.
    Krupke DM; Fuller J; Aslakson C; Evans R
    Nat Immun; 1994; 13(5):246-57. PubMed ID: 7833624
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Optimal scheduling of interleukin 12 and chemotherapy in the murine MB-49 bladder carcinoma and B16 melanoma.
    Teicher BA; Ara G; Buxton D; Leonard J; Schaub RG
    Clin Cancer Res; 1997 Sep; 3(9):1661-7. PubMed ID: 9815857
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Concomitant inhibition of tumor-associated inflammatory responses and rapid enhancement of cyclophosphamide-induced tumor regression by hydrocortisone.
    Evans R; Eidlen DM
    Cancer Res; 1982 Nov; 42(11):4437-42. PubMed ID: 7127285
    [No Abstract]   [Full Text] [Related]  

  • 38. Synergistic antitumor activity of histamine plus melphalan in isolated limb perfusion: preclinical studies.
    Brunstein F; Hoving S; Seynhaeve AL; van Tiel ST; Guetens G; de Bruijn EA; Eggermont AM; ten Hagen TL
    J Natl Cancer Inst; 2004 Nov; 96(21):1603-10. PubMed ID: 15523089
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Isolated lung perfusion with cisplatin in a rat lung solitary tumor nodule model.
    Li TS; Sugi K; Ueda K; Nawata K; Nawata S; Esato K
    Anticancer Res; 1998; 18(6A):4171-6. PubMed ID: 9891463
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Antitumor activity of menogaril alone, and in combination against human mammary cancer models in mice and rats.
    Yoshida M; Fujioka A; Nakano K; Kobunai T; Saito H; Toko T; Takeda S; Unemi N
    Anticancer Res; 1996; 16(3A):1155-9. PubMed ID: 8702227
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.